Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 13, 2023

SELL
$86.68 - $100.3 $11,441 - $13,239
-132 Reduced 5.22%
2,398 $207,000
Q2 2023

Aug 10, 2023

SELL
$86.68 - $100.3 $11,441 - $13,239
-132 Reduced 5.22%
2,398 $208,000
Q1 2023

Nov 13, 2023

BUY
$87.74 - $117.27 $1,754 - $2,345
20 Added 0.8%
2,530 $246,000
Q1 2023

May 16, 2023

BUY
$87.74 - $117.27 $1,754 - $2,345
20 Added 0.8%
2,530 $246,000
Q4 2022

Nov 13, 2023

BUY
$80.93 - $108.63 $9,064 - $12,166
112 Added 4.67%
2,510 $259,000
Q2 2022

Aug 08, 2022

BUY
$71.48 - $86.85 $179,414 - $217,993
2,510 New
2,510 $208,000
Q1 2022

May 12, 2022

SELL
$74.28 - $92.69 $186,442 - $232,651
-2,510 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$71.72 - $91.47 $5,737 - $7,317
-80 Reduced 3.09%
2,510 $222,000
Q3 2021

Nov 04, 2021

SELL
$74.77 - $85.47 $34,244 - $39,145
-458 Reduced 15.03%
2,590 $200,000
Q2 2021

Aug 09, 2021

BUY
$75.51 - $84.79 $5,210 - $5,850
69 Added 2.32%
3,048 $254,000
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $34,450 - $41,808
-461 Reduced 13.4%
2,979 $225,000
Q4 2020

Feb 09, 2021

SELL
$72.61 - $90.2 $15,102 - $18,761
-208 Reduced 5.7%
3,440 $302,000
Q3 2020

Nov 05, 2020

SELL
$71.87 - $131.03 $5,174 - $9,434
-72 Reduced 1.94%
3,648 $278,000
Q2 2020

Jul 30, 2020

SELL
$79.55 - $124.22 $24,421 - $38,135
-307 Reduced 7.62%
3,720 $459,000
Q1 2020

May 08, 2020

BUY
$71.37 - $96.85 $6,566 - $8,910
92 Added 2.34%
4,027 $340,000
Q4 2019

Feb 06, 2020

SELL
$64.27 - $86.37 $57,778 - $77,646
-899 Reduced 18.6%
3,935 $333,000
Q3 2019

Oct 29, 2019

SELL
$67.4 - $85.11 $9,840 - $12,426
-146 Reduced 2.93%
4,834 $326,000
Q2 2019

Aug 29, 2019

SELL
$80.35 - $93.9 $9,320 - $10,892
-116 Reduced 2.28%
4,980 $427,000
Q1 2019

May 13, 2019

SELL
$84.2 - $98.62 $114,259 - $133,827
-1,357 Reduced 21.03%
5,096 $453,000
Q4 2018

Feb 15, 2019

SELL
$80.14 - $106.07 $36,303 - $48,049
-453 Reduced 6.56%
6,453 $549,000
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $648,611 - $730,102
6,906 New
6,906 $670,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.